{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:33:22Z","timestamp":1791160402044,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.vaccine.2003.10.008","type":"journal-article","created":{"date-parts":[[2003,11,15]],"date-time":"2003-11-15T08:16:36Z","timestamp":1068884196000},"page":"915-922","source":"Crossref","is-referenced-by-count":44,"title":["Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge"],"prefix":"10.1016","volume":"22","author":[{"given":"Leon","family":"de Waal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ultan F.","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"van Amerongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thien N.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert G.M.","family":"Niesters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik L.","family":"de Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.M.E.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.10.008_BIB1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(99)80040-3","article-title":"Respiratory syncytial virus infection","volume":"354","author":"Simoes","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.10.008_BIB2","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0264-410X(01)00287-0","article-title":"Respiratory syncytial virus vaccine development","volume":"20","author":"Crowe","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.10.008_BIB3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am. J. Epidemiol"},{"key":"10.1016\/j.vaccine.2003.10.008_BIB4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/jama.202.12.1075","article-title":"Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated virus vaccines","volume":"202","author":"Fulginiti","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2003.10.008_BIB5","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1099\/0022-1317-82-12-2881","article-title":"Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine","volume":"82","author":"Prince","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vaccine.2003.10.008_BIB6","doi-asserted-by":"crossref","first-page":"11561","DOI":"10.1128\/JVI.76.22.11561-11569.2002","article-title":"Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection","volume":"76","author":"De Swart","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2003.10.008_BIB7","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0264-410X(01)00301-2","article-title":"Immunopathogenesis of vaccine-enhanced RSV disease","volume":"20","author":"Openshaw","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.10.008_BIB8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.10.008_BIB9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2002.1431","article-title":"Respiratory syncytial virus immunobiology and pathogenesis","volume":"297","author":"Graham","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2003.10.008_BIB10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/viro.1997.8465","article-title":"Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment","volume":"230","author":"Power","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2003.10.008_BIB11","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1086\/514075","article-title":"Challenge of BALB\/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide","volume":"176","author":"Corvaia","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.008_BIB12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/viro.1999.9702","article-title":"Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment","volume":"258","author":"Plotnicky-Gilquin","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2003.10.008_BIB13","doi-asserted-by":"crossref","first-page":"12421","DOI":"10.1128\/JVI.75.24.12421-12430.2001","article-title":"Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice","volume":"75","author":"Power","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2003.10.008_BIB14","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/S0264-410X(03)00055-0","article-title":"Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate","volume":"21","author":"Plotnicky","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.10.008_BIB15","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1086\/314778","article-title":"Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: influence of adjuvants and maternal antibodies","volume":"179","author":"Siegrist","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.008_BIB16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1086\/324426","article-title":"Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults","volume":"184","author":"Power","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.008_BIB17","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1016\/S0264-410X(01)00168-2","article-title":"A novel bipolar mode of attachment to aluminium-containing adjuvants by BBG2Na, a recombinant subunit hRSV vaccine","volume":"19","author":"Dagouassat","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.10.008_BIB18","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1128\/JVI.74.9.4236-4243.2000","article-title":"Protective immunity in macaques vaccinated with a modified Vaccinia virus Ankara-based measles vaccine in the presence of passively acquired antibodies","volume":"74","author":"Stittelaar","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2003.10.008_BIB19","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.vaccine.2003.10.008_BIB20","unstructured":"Trudel M, Power UF, Stahl S, Bonnefoy JY, Nguyen TN. Immunogenicity and protective efficacy of an RSV subunit vaccine candidate BBG2Na in African green monkeys. Abstract, San Diego: ICAAC; 1998."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T20:52:43Z","timestamp":1550350363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03007424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0264410X03007424"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.10.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}